The fourth (re- )classification of cardiopericardial tumours came from the World Health Organisation last year, 11 years after the third. In particular, the malignant fibrous histiocytomas are re classified as undifferentiated pleomorphic sarcomas.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Thoracic
September 30, 2015
A Spanish cancer patient has received a 3D printed titanium sternum and rib cage designed and manufactured right here in Australia, at our Melbourne-based 3D printing facility in Melbourne.
September 10, 2015
This article presents a detailed summary of the diagnosis, staging, and surgical management of early stage thymic malignancies.
July 23, 2015
The paper presents the guidelines for authors on statistical and data reporting for the European Journal of Cardio-Thoracic Surgery (EJCTS) and the Interactive CardioVascular and Thoracic Surgery (ICVTS). It focusses on issues which are most frequently commented on by the statistical reviewers.
June 16, 2015
The British Thoracic Society developed guidelines for evaluation and management of solitary pulmonary nodules based on a literature review and expert opinion. New features include the use of a malignancy risk algorithm, use of a higher threshold for follow-up (5mm), and a reduction in the follow-up interval to 1 year for solid nodules. Management o
April 7, 2015
In this interview, filmed at the 2015 STS Annual meeting, Joel Dunning and Shanda Blackmon discuss a variety of thoracic surgery topics.
November 11, 2014
CMS determined that the evidence of benefit for CT screening for lung cancer is sufficient to permit this as an annual benefit for Medicare and Medicaid recipients in the US. The availability of such coverage will be limited, however, by the need to have the screening as part of a comprehensive counseling (smoking cessation, etc) visit with qualifie
November 5, 2014
The authors examined cost-effectiveness in the National Lung Screening Trial (NLST), examining incremental cost-effectiveness ratio (ICER) and quality-adjusted life years (QALYs) associated with low dose CT screening. The ICER was $52,000 per life-year gained and the $81,000 per QALY gained. These values were very sensitive to variations in the scr
October 12, 2014
This is a fabulous paper comparing VATS versus open lobectomy. The 5 year survival is the same, the hospital stay is 2 days less and the in hospital mortality is slightly lower
August 2, 2014
2014 consensus guidelines on the perioperative evaluation and management of patients undergoing NONCARDIAC surgery.